Atlas Trials

Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome

Clinical trial NCT03271866 · UNKNOWN

Trial details

NCT number
NCT03271866
Sponsor
Central South University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia
Start date
2017-08-28
Primary completion
2023-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.